Navigation Links
UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline
Date:6/18/2013

A UT Arlington environmental engineer has been awarded a $394,300 grant from the Tarrant Regional Water District to ensure water quality and flow in the new facilities of the 150-mile Integrated Pipeline Project.

Andrew Kruzic, UT Arlington associate professor of civil engineering, will investigate the best methods and locations to add monochloramine to the water in an effort to eliminate biological growths in the new pump stations and pipelines. Adding monochloramine is widely practiced throughout the United States.

Biological growth decreases the flow rate in the pipelines and increase the cost to deliver the water.

The monochloramines will be removing biofilm and invasive species, such as the zebra mussels, that have infested some North Texas lakes. Kruzic also will study how to inhibit internal corrosion, and recommend locations along the pipeline for water treatment.

"As North Texas builds the $2.3 billion, 150-mile pipeline from Lake Palestine in East Texas to Tarrant County, the builders have to ensure what they're getting will be as efficient and last as long as possible," Kruzic said. "We want to make sure the pipeline is flowing as much water as possible to North Texas."

The first portion of the pipeline is scheduled to be operational by 2021 and will deliver up to 350 million gallons of raw water per day to North Texas. The Tarrant Regional Water District and Dallas Water Utilities are teaming together for the project. TRWD has 70 customer cities. DWU has 27 customer cities. Together, the two providers supply water to more than 4.4 million people in 13 North Texas counties.

"Dr. Kruzic's research is necessary to help us operate the pipeline efficiently, while also meeting the targeted project-life of 100 years," said David Marshall, engineering services director for the Tarrant Regional Water District. "The Integrated Pipeline Project is critical to ensuring water supplies to support long term growth in North Texas."

Currently, water utilities rely on monochloramine, a combination of chloride and ammonia, to disinfect and protect water supplies from disease-causing microorganisms, Kruzic said.

Kruzic is teaming with Kevin Schug, a UT Arlington associate professor of chemistry and biochemistry, in the research. Schug also is the Shimadzu Distinguished Professor of Analytical Chemistry. His work is based in the Shimadzu Center for Advanced Analytical Chemistry at UT Arlington. The research will rely on one of Shimadzu's chemical analysis machines.

Kruzic also said that he will serve as a consultant to the Tarrant Regional Water District to choose instrumentation for chemical and environmental monitoring on the pipeline. Finally, part of the grant calls for Kruzic to help incorporate the research results into final design for the pipeline.

Khosrow Behbehani, dean of the UT Arlington College of Engineering, said Dr. Kruzic's work is vital to ensure continued growth in North Texas.

"This pipeline can get needed water resources to North Texas," Behbehani said. "Dr. Kruzic's research will have long-lasting impact on providing safe water for current and future North Texas residents and businesses. His methods and procedures certainly could be used by future projects involving large volumes of water."


'/>"/>

Contact: Herb Booth
hbooth@uta.edu
817-272-7075
University of Texas at Arlington
Source:Eurekalert

Related biology news :

1. UT Arlington engineer to search for bad algal blooms
2. UT Arlington bioengineer to use hybrid imaging system to see deep tissue
3. UT Arlington engineer wins NSF award to support microfluidic analyses of tissue, cell samples
4. National Academy of Inventors names four UT Arlington professors as charter fellows
5. UT Arlington physics team demonstrates new power generation technique
6. National herpetology society honors UT Arlington professor for discoveries
7. Wayne State welcomes undergraduates from around the US for physics research experience
8. Saint Louis University researchers discover a way to detect new viruses
9. NIH fellowship helps researcher fight malaria, understand mosquito immunity
10. OU researchers collaborate on $20 million NSF EPSCoR grant
11. Researchers unearth bioenergy potential in leaf-cutter ant communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... 12, 2016  Researchers at Trinity College, Dublin, ... by combining the material with Silly Putty. The mixture ... detector able to sense pulse, blood pressure, respiration, ... The research team,s findings were ... here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Opal Kelly, a leading producer ... Express, announced the ZEM5310 USB 3.0 FPGA Module, combining a SuperSpeed USB 3.0 ... form factor suitable for prototyping, testing, and production-ready integration. The ZEM5310 USB interface ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... for Clinical Ops Executives 2017 in its continued commitment to the advancement of ... makers to discuss current issues related to clinical trial planning and management. ...
(Date:1/18/2017)... NY (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... do not fall low enough after prostate cancer treatment, this indicates there is still remaining ... risk of mortality. , “ The PSA test has always been an indicator of whether ...
(Date:1/18/2017)... Shareholder rights law firm Johnson & Weaver, ... members of CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD ... proposed sale of the Company to Eli Lilly and ... molecules for the acute treatment of migraines. ... a definitive merger agreement with Eli Lilly. Under the ...
Breaking Biology Technology: